- Home
- MGEE vs ICUI Comparison
MGEE vs ICUI Comparison
Compare MGEE & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGEE
- ICUI
- Stock Information
- Founded
- MGEE 1855
- ICUI 1984
- Country
- MGEE United States
- ICUI United States
- Employees
- MGEE N/A
- ICUI N/A
- Industry
- MGEE Electric Utilities: Central
- ICUI Medical/Dental Instruments
- Sector
- MGEE Energy
- ICUI Health Care
- Exchange
- MGEE Nasdaq
- ICUI Nasdaq
- Market Cap
- MGEE 3.1B
- ICUI 3.2B
- IPO Year
- MGEE N/A
- ICUI 1992
- Fundamental
- Price
- MGEE $83.03
- ICUI $136.00
- Analyst Decision
- MGEE Sell
- ICUI Buy
- Analyst Count
- MGEE 2
- ICUI 6
- Target Price
- MGEE $79.00
- ICUI $183.60
- AVG Volume (30 Days)
- MGEE 116.9K
- ICUI 297.6K
- Earning Date
- MGEE 11-05-2025
- ICUI 11-06-2025
- Dividend Yield
- MGEE 2.27%
- ICUI N/A
- EPS Growth
- MGEE 12.85
- ICUI N/A
- EPS
- MGEE 3.69
- ICUI N/A
- Revenue
- MGEE $708,516,000.00
- ICUI $2,320,363,000.00
- Revenue This Year
- MGEE $10.69
- ICUI N/A
- Revenue Next Year
- MGEE $3.32
- ICUI N/A
- P/E Ratio
- MGEE $22.67
- ICUI N/A
- Revenue Growth
- MGEE 8.39
- ICUI N/A
- 52 Week Low
- MGEE $81.13
- ICUI $107.00
- 52 Week High
- MGEE $108.64
- ICUI $175.51
- Technical
- Relative Strength Index (RSI)
- MGEE 43.63
- ICUI 61.02
- Support Level
- MGEE $82.28
- ICUI $134.24
- Resistance Level
- MGEE $84.75
- ICUI $144.85
- Average True Range (ATR)
- MGEE 1.52
- ICUI 5.58
- MACD
- MGEE -0.09
- ICUI 1.14
- Stochastic Oscillator
- MGEE 48.23
- ICUI 58.70
About MGEE MGE Energy Inc
MGE Energy provides electric service to 161,000 customers and natural gas service to 173,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.